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Hepatitis E virus (HEV) is the causative agent of acute hepatitis E in humans in developing countries, but sporadic
and autochthonous cases do also occur in industrialised countries. In Europe, food-borne zoonotic transmission of
genotype 3 (gt3) has been associated with domestic pig and wild boar. However, little is known about the course
of HEV infection in European wild boar and their role in HEV transmission to domestic pigs. To investigate the
transmissibility and pathogenesis of wild boar-derived HEVgt3, we inoculated four wild boar and four miniature
pigs intravenously. Using quantitative real-time RT-PCR viral RNA was detected in serum, faeces and in liver, spleen
and lymph nodes. The antibody response evolved after fourteen days post inoculation. Histopathological findings
included mild to moderate lymphoplasmacytic hepatitis which was more prominent in wild boar than in miniature
pigs. By immunohistochemical methods, viral antigens were detected mainly in Kupffer cells and liver sinusoidal
endothelial cells, partially associated with hepatic lesions, but also in spleen and lymph nodes. While clinical
symptoms were subtle and gross pathology was inconspicuous, increased liver enzyme levels in serum indicated
hepatocellular injury. As the faecal-oral route is supposed to be the most likely transmission route, we included
four contact animals to prove horizontal transmission. Interestingly, HEVgt3-infection was also detected in wild
boar and miniature pigs kept in contact to intravenously inoculated wild boar. Given the high virus loads and
long duration of viral shedding, wild boar has to be considered as an important HEV reservoir and transmission
host in Europe.Introduction
Hepatitis E virus (HEV) is the causative agent of hepa-
titis E in humans and the sole member of the genus
Hepevirus in the family Hepeviridae. It is a small, non-
enveloped virus with a single-stranded RNA genome of
positive polarity [1,2]. In many developing countries
where sanitary conditions are suboptimal, hepatitis E is
an important public health problem, with the virus being
primarily transmitted via the fecal-oral route through
contaminated food or water [3]. However, emerging
cases of sporadic and autochthonous hepatitis E also
occur in industrialised countries, including Japan and
European countries [4-6]. HEV infections are known to* Correspondence: Martin.Groschup@fli.bund.de
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unless otherwise stated.be responsible for acute hepatitis, however, HEV geno-
type 3 was recently also identified in Europe in severely
immunocompromised patients as a new causative agent of
chronic hepatitis [7,8]. Four genotypes (gt) of HEV (gt1 to
gt4) infecting humans have been identified. Gt1 and gt2
are restricted to humans, and gt3 and gt4 are zoonotic
with wild boar, domestic pig and deer representing reser-
voirs [9,10]. Although a consensus classification system
for HEV genotypes is currently unavailable, HEV variants
from Japanese wild boar (Scrofa scrofa leucomystax) have
provisionally been classified into two novel genotypes (gt5
and gt6) [11]. The identification and characterization of
additional HEV strains in chicken, rabbit, different rat
species, and mongoose have significantly broadened the
host range and diversity of HEV [12,13]. Recently, novel
HEV-related viruses were identified in carnivores such as
ferret [14] and fox [15], different bat species [16], mooseal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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to non-human primates and pigs have been shown experi-
mentally for gt3 and gt4 [19]. Severe human HEV infec-
tion after ingestion of uncooked liver from wild boar
S. scrofa leucomystax) was reported in Japan, whereas
food-borne zoonotic transmissions in Europe have been
primarily associated with domestic pigs [4,20]. Further-
more, individuals with direct contact to pigs are at higher
risk of HEV infection and as previously shown, forestry
workers have a higher HEV seroprevalence rate com-
pared to blood donors [21-23]. Recent studies in Asia
and Europe revealed high HEV seroprevalences and mo-
lecular evidence for HEV infection in wild boar [24-31].
In Germany, wild boar is discussed as one of the main
sources of human autochthonous infections [32,33].
Moreover, phylogenetic analyses of Japanese HEV iso-
lates indicated former transmission events from domes-
tic pig to wild boar [34].
Until now several studies in domestic pigs have been
performed by intravenous or contact transmission of do-
mestic pig-derived HEV [35-40], showing histopatho-
logical signs of a hepatitis but no clinical symptoms
[37,41,42]. Conversely, little is known about the course
of HEV infection in European wild boar and their role in
HEV transmission to domestic pigs to date. Experimen-
tal challenge studies have not been carried out yet.
Therefore, the aim of this study was to investigate the
pathogenesis of a wild boar-derived HEV gt3 strain after
experimental inoculation and to reveal possible horizon-
tal transmissions to miniature pigs (S. scrofa domestica)
and European wild boar (S. scrofa scrofa).
Materials and methods
Inoculum
The HEV gt3 strain used in this study originated from a
liver sample of a naturally infected wild boar hunted in
Northern Germany (Mecklenburg-Western Pomerania)
in 2010. The liver was frozen immediately at −20 °C and
stored at −70 °C. For preparation of the inoculum, the
liver was ground in phosphate-buffered saline (PBS) with
a mortar and pestle (10%, w/v). The suspension was
transferred to a 15 mL tube and mixed for 1 min using a
vortex mixer. After centrifugation (20 min at 4000 × g at
4 °C) the supernatant was transferred to a new tube and
filtered (0.22 μm MILLEX®GP filter unit, Millipore,
Ireland). The suspension was aliquoted in volumes of 2.5
mL and stored at −70 °C. The inoculum contained about
2 × 104 HEV RNA copies per μL RNA.
Experimental design
Seven sub-adult miniature pigs of three months age,
three wild boar piglets of three months age and two
adult wild boar of six month age were used in the ex-
periment under biosafety level 3** conditions. Prior tothe start of the experiment all animals were tested to be
negative for anti-HEV antibodies in serum and HEV
RNA in faeces, respectively. The wild boar piglets used
in the study were obtained from a local farmer. Mini-
ature pigs and adult wild boar were bred in the quaran-
tine facilities at the Friedrich-Loeffler-Institut, Insel
Riems, Germany. Following an initial clinical examin-
ation, including rectal body temperature, wild boar were
allowed to accustom themselves to new surroundings for
approximately 1–2 weeks prior to the initiation of exper-
iments. The animals were fed with commercial pig feed
and had access to water ad libitum. Two additional
miniature pigs and one additional wild boar served as
negative controls and were housed separately. Control
animals remained negative for the whole experiment and
were not considered further on in this manuscript.
All animals were observed daily during the entire period
of the experiment. In Group 1 and Group 2, four wild
boar (wb93, wb95, wb10 and wb11) and four miniature
pigs (mp30, mp37, mp39 and mp40) were inoculated
intravenously via the vena cava cranialis with 2.0 mL
liver suspension each. For the direct contact infection
experiment (Group 3), one non-inoculated wild boar
piglet (wb87) was kept together with the intravenously
inoculated wild boar piglets (wb93 and wb95). For ani-
mal welfare reasons three miniature pigs (mp63, mp68
and mp79) were kept in an adjacent compartment. To
facilitate an indirect transmission, excrements of intra-
venously inoculated wild boar (wb93 and wb95) were
placed daily into stable of miniature pigs. Conveniently,
time points of the experiment were designated as days
post inoculation (dpi). An overview of the animal experi-
ment is shown in Table 1.
Measurements of the body weight and rectal temperature
as well as collection of blood and faecal samples were done
at time points 0, 1, 3, 5, 8, 11, 14, 17, 21, 24, 27, 29 dpi in
Group 2 and 0, 3, 7, 10, 14, 17, 21, 25, 28 dpi in Group 1
and 3. Fever was defined as a body temperature ≥40.0 °C
for at least two consecutive days. Aliquots of serum
samples were stored at −20 °C for antibody detection
and clinical chemistry, and at −70 °C for RNA extraction.
Faecal samples were diluted in isotonic saline solution
(10%, w/v) and stored at −70 °C for RNA extraction. The
experiment was finished after 29 dpi (Group 2) or after
28 dpi (Group 1 and 3). At necropsy, tissue samples
(liver, liver lymph node, mesenteric and mandibular
lymph nodes, gall bladder, small and large intestine,
pancreas, kidney, spleen, tonsil, heart, brain, gonads,
uterus or prostate, and quadriceps femoris muscle)
were collected for virological, histopathological and
immunohistochemical investigations. One part of each
tissue sample was fixed immediately in 4% neutral buff-
ered formalin for histological examination and the other
part was stored at −70 °C for RNA extraction.
Table 1 Overview of the animal experiment
Group no. Animal Sex Age (in
months)
Clinical signs and blood
chemistry*
Gross lesions Liver histopathology Viral antigens in liver by IHC
Grading Distribution
Group 1. Intravenous
inoculation of wild boar
wb93 ♀ 3 both with reduced feed
intake, mild diarrhea, BA,
ALT and γGT ↑
in all animals mild hyperplasia of
liver lymph nodes and lymphoid
tissue in large intestine
both with panlobular hepatocellular
swelling, vacuolation and single
cell necrosis of hepatocytes
+++ diffuse mainly in Kupffer
cells and LSEC
wb95 ♀ 3 ++
wb10 ♂ 6 both with γGT ↑ both with multifocal lymphoplasmacytic
infiltrates and hepatocellular
degeneration (mainly centrilobular)
+++ mainly centrilobular in
Kupffer cells associated with




mp30** ♀ 3 γGT ↑ (not in mp30) nematodes in gut and milk spots
in liver (mp39)
multifocal lymphoplasmacytic
infiltrates and single cell necrosis
of hepatocytes (mp37 and mp39)
0 diffuse mainly in Kupffer
cells and LSEC
mp37 ♀ 3 +
mp39 ♀ 3 ++
mp40 ♀ 3 0
Group 3. Contact infection
of wild boar and miniature
pigs
wb87 ♂ 3 reduced feed intake, mild
diarrhea, BA, ALT and γGT ↑
mild hyperplasia of liver and
intestinal lymph nodes, altered
liver consistency and milk spots,
moderate splenomegaly
intralobular lymphohistiocytic
infiltrates and single cell necrosis
of hepatocytes
++ mainly centrilobular in
Kupffer cells and LSEC
mp63 ♀ 3 all with γGT ↑ mild hyperplasia of lymphoid
tissue in large intestine, nematodes
in gut and renal cyst (mp68)
all with mild lymphohistiocytic
infiltrates within liver lobules
0 -
mp68 ♂ 3 0
mp79 ♀ 3 0
Tissues were taken on days 29 (Group 2) and 28 (Group 1, Group 3). Grades are formulated on a result of viral antigen density throughout a uniform tissue type. Sections were graded on two separate occasions,
without referring to previous recorded results to help standardize the classification. Definition of immunolabelling grades as: 0 = no antigen staining seen, + = mild immunolabelling, ++ = moderate antigen staining,














Table 2 Primers and probe used in this study
Region Primers and probe Position Sequence Product
length













Probe (HEV.P) 5300-5320 FAM-TGACMG
GGTTGATTCTC
AGCC-BHQ1
ORF = open reading frame.
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authority of the Federal State of Mecklenburg-Western
Pomerania, Germany, on the basis of national and European
legislation, namely the EU council directive 86/609/EEC
for the protection of animals used for experiments (LALLF
M-V/TSD/7221.3-2.1.-014/10).
Clinical chemistry
Serum samples were analysed longitudinally by a spectro-
photometric method in an automated analyzer (VetScan
Chemistry Analyzer, Abaxis, Union City, USA) using spe-
cial rotors (VetScan Mammalian Liver Profile reagent
rotor, Abaxis) to provide quantitative determinations for
alanine aminotransferase (ALT), albumin (ALB), alkaline
phosphatase (ALP), bile acids (BA), total bilirubin (TBIL),
total cholesterol (CHOL), gamma-glutamyl transferase
(γGT) and blood urea nitrogen (BUN) in serum. For the
evaluation of the results, upper reference value ranges
for the tested biochemical parameters were calculated.
Therefore, different serum samples of the negative con-
trol wild boar and miniature pigs were analysed (for
each subspecies n =13).
Antibody and RNA detection
Sera were tested for the presence of total anti-HEV anti-
bodies with a species independent HEV-Ab ELISA kit
(Axiom, Bürstadt, Germany) according to the manufac-
turer’s instructions. The ELISA uses recombinant HEV
gt1 antigens for the detection of anti-HEV antibodies in
serum or plasma. Values of the optical density at 450
nm (OD450) equal to or greater than 1 are prescribed as
seropositive.
Manual extraction of viral RNA from all serum sam-
ples and faecal suspensions was performed using the
QIAamp® Viral RNA Mini Kit (QIAGEN GmbH, Hilden,
Germany) according to manufacturer’s recommenda-
tions. From all tissue samples, viral RNA was extracted
using the RNeasy Mini Kit (QIAGEN GmbH). For
both extraction methods, an internal control RNA (IC2)
was added as described previously [43]. HEV RNA was
detected by a novel diagnostic quantitative real-time RT-
PCR assay (RT-qPCR) using the CFX96™ Real-Time Sys-
tem (Bio-Rad Laboratories GmbH, München, Germany).
All primer and probes used in this study are listed in
Table 2. The RT-qPCR was performed using the Quanti-
Tec Probe RT-PCR kit (QIAGEN GmbH) in 25 μL reac-
tion volume with final concentrations of each primer with
0.8 μM, and of the probe with 0.1 μM. A volume of 5 μL
RNA was added. Reverse transcription (RT) was carried
out at 50 °C for 30 min, followed by denaturation/activa-
tion at 95 °C for 15 min. DNA was amplified immediately
with 45 cycles at 95 °C (10 s), 55 °C (25 s) and 72 °C
(25 s). The determination of the HEV copy number was
carried out using a standard curve according to a syntheticexternal calibrator encompassing the 81 bp sequence of
the RT-qPCR amplicon.Histopathology and immunohistochemistry
For histopathological examinations formalin fixed tissue
samples were stained with hematoxylin and eosin (HE)
according to standard protocols. For immunohistochemis-
try (IHC) 3 μm sections were cut, deparaffinised and rehy-
drated. The pretreatment included a blocking step for
the endogenous peroxidase using 3% H2O2/methanol
for 30 min, followed by an antigen retrieval step in the
microwave for 10 min at 600 W. A 1:200 diluted commer-
cially available polyclonal rabbit anti-human CD3 antibody
(Dako Deutschland GmbH, Hamburg, Germany), which
is also binding to porcine CD3 antigen, was used to
characterise the inflammatory response in the liver. Viral
antigens were detected using a rabbit anti-HEV gt3 hyper-
immune serum (rHEVgt3-HIS) in a 1:1000 dilution. For
the production of this serum, a rabbit was immunised with
an Escherichia coli expressed and purified His-tagged
C-terminal segment of HEV gt3 capsid protein [21]. The
slides were incubated with biotinylated goat anti-rabbit im-
munoglobulin (Vector Laboratories, LINARIS, Dossenheim,
Germany) and an avidin/biotinylated enzyme complex (VEC-
TASTAIN®ABC Reagent, Vector Laboratories, Burlingame,
United States of America) followed by visualisation with 3,3-
Diaminobenzidine (DAB, Sigma-Aldrich Chemie GmbH,
Steinheim, Germany). The viral antigen density was graded as
follows: 0 = no antigen staining seen; + = mild immunolabel-
ling (<20% positive cells); ++ = moderate antigen staining
(20 – 40% positive cells); +++ = marked immunolabelling
(>40% positive cells). The sections were examined inde-
pendently on two separate occasions.Results
Experiments were carried out to determine i.) the patho-
genesis of wild boar-derived HEV gt3 in wild boar and
miniature pigs (Groups 1 and 2), and ii.) the horizontal
transmissibility following such infections (Group 3).
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miniature pigs (Group 2) with HEV gt3 of wild
boar origin:
Clinical and biochemical parameters
Intravenously inoculated wild boar did not develop a
significant rise in their body temperatures. Only wb93
and wb95 developed moderate clinical signs such as
mild depression, slight diarrhea and mild anorexia, and
displayed an increase in the BA and γGT serum levels.
An elevated ALT level was only observed in wb93. In-
crease of γGT levels were observed in all intravenously
infected wild boar after 21 dpi. Interestingly, ALT and
γGT serum levels returned to normal in wb93 after day
25. None of the intravenously inoculated miniature pigs
showed febrile temperatures or any other clinical signs,
and none of these animals had altered BA serum levels.
Increased γGT levels were observed in mp39 and mp40
at 29 dpi, whereas an elevation of the ALT level was only
seen in mp39. An overview of the clinical signs is given
in Table 1. Figure 1 depicts the time line of serum levels
of BA, ALT and γGT. Other biochemical parameters
remained within normal limits (data not shown).
Serology and HEV RNA detection
Two of the four intravenously inoculated wild boar
(wb10 and wb11) seroconverted after 17 dpi, whereas
the other two (wb93 and wb93) showed no seroconver-
sion during the observation period (28 days). In the
intravenously inoculated miniature pigs antibodies were
detected first time in mp37 and mp40 at 14 dpi, whereas
mp39 seroconverted thirteen days later. The serological
results regarding HEV antibodies are shown in Figure 2A.
HEV RNA with copy numbers exceeding 10 copies per
μL RNA was found in the sera of two intravenously in-
oculated wild boar (wb93 at 17, 25, 28 dpi and wb95 at
21 dpi). Viral RNA was detectable in faeces of all wild
boar within 3 to 5 dpi at levels of up to 105 copies per
μL RNA (wb93, wb95 and wb11). In the two wild boar
without seroconversion (wb93 and wb95), RNA copy
numbers in faeces persisted until to the end of the ex-
periment, albeit at slightly reduced levels. The two ani-
mals which seroconverted (wb10 and wb11) showed a
marked reduction of faecal HEV shedding (< 101 copies
per μL RNA) eventually. Viral RNAs were detected in
liver, gall bladder, caecum, colon and spleen of all intra-
venously inoculated wild boar. In wb95 positive signals
(>20 copies per μL RNA) were also found in brain,
muscle and uterus. In general, comparable RNA copy
numbers in serum and faeces were found in the mini-
ature pigs. A marked decrease of faecal HEV shedding
was also observed in two miniature pigs which serocon-
verted within 14 dpi (mp37 and mp40). In most of the
intravenously infected miniature pigs viral RNAs werealso detected in liver, gall bladder, caecum, colon and
spleen. Already at 1 dpi, relatively high viral RNA copy
numbers were found in the liver of mp30. The results of
HEV RNA in serum and faeces are shown in Figure 2B.
Table 3 summarises the viral loads of selected tissue
samples. Additionally, HEV RNA was found in bile of
wb93, wb95, wb11 and mp39.
Pathology
No gross pathological changes specific for viral hepatitis
were seen in the livers of any of the pigs. However, macro-
scopic signs like mild to moderate follicular hyperplasia of
lymphoid tissues in large intestine and mild hyperplasia of
liver lymph nodes in intravenously inoculated wild boar
were seen in some animals. Necropsy revealed also moder-
ate intestinal nematode infestations and multifocal white
spots (“milk spots”) in the liver characteristic for chronic
infection with Ascaris suum. Intralobular lesions of differ-
ent sizes, patterns and frequencies associated with varying
distribution of viral antigens were observed in the liver of
intravenously inoculated pigs, but not in the negative con-
trol animals. Mild to moderate periportal lymphoplasmacy-
tic infiltrates and Kupffer cell proliferations were also
found in the liver of all intravenously inoculated pigs. How-
ever, no viral antigens were detected in periportal fields. By
immunohistochemistry, viral antigens within hepatic lob-
ules were found mainly in Kupffer cells and liver sinusoidal
endothelial cells, and to a lesser extent in hepatocytes. Par-
tially, hepatic lesions and infiltrates of CD3-positive cells
were associated with viral antigens in Kupffer cells and
liver sinusoidal endothelial cells. In detail, the liver of intra-
venously inoculated wild boar showed a more heteroge-
neous pattern in comparison to the miniature pigs. Two
animals (wb93 and wb95) revealed a mild to moderate
multifocal intralobular lymphohistiocytic infiltration with
multifocal hepatocellular swelling and vacuolation, and a
diffuse viral antigen distribution (Figure 3A-D). However,
more severe liver lesions were observed in the two other
intravenously inoculated wild boar (wb10 and wb11), with
a pronounced mainly centrilobular hepatocellular degener-
ation associated with infiltrates of lymphocytes, plasma
cells and Kupffer cells (Figure 3E and F). These lesions
were clearly associated with a marked immunolabelling of
viral antigens (Figure 3G and H). The liver of intravenously
inoculated miniature pigs displayed diffuse mild intra-
lobular lymphoplasmacytic infiltrations with single cell
necrosis of hepatocytes and small to moderate amounts of
diffusely distributed viral antigens (Figure 3I-L). In some
animals, viral antigens were also found in the sub-capsular
layer and follicles of distinct lymph nodes and in the ger-
minal centre of lymphoid follicles in spleen (Figure 4A
and B). In none of the other tested tissues viral antigens
were found. An overview of gross lesions, histopathology
and immunohistochemistry is given in Table 1. All IHC
Figure 1 Detection of bile acids (BA), alanine aminotransferase (ALT) and gamma-glutamyl transferase (γGT) in serum. Group 1:
Intravenous inoculation of wild boar. Group 2: Intravenous inoculation of miniature pigs. Group 3: Contact infection of wild boar and miniature
pigs. For the evaluation of the results, upper reference value ranges for the tested biochemical parameters were calculated. Therefore, different
serum samples of the negative control wild boar and miniature pigs were analysed (for each subspecies n =13). Upper reference range limit for
wild boar = grey dot-dashed line. Upper reference range limit for miniature pig = grey dot-dot-dashed line. IU = international units. * Sudden
death at 1 dpi (after blood collection).
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Additional file 1.
ii.) Transmission of HEV gt3 from intravenously
inoculated wild boar to contact wild boar and
miniature pigs (Group 3).
Clinical and biochemical parameters
None of the contact animals became pyrexic. Only wb87
showed moderate clinical signs characterized by mild
depression, slight diarrhea and reduced feed intake in
combination with elevated BA and ALT serum levels
after 25 dpi. In the contact miniature pig mp79 a slight
increase of BA in serum was also observed (7 to 17 dpi).
All contact animals had increased γGT serum levels at
different time points, most strikingly in mp68 at 7 dpi.
An overview of the clinical signs is given in Table 1.Figure 1 depicts the time lines of serum levels of BA,
ALT and γGT. Other tested biochemical parameters
remained within normal limits (data not shown).
Serology and HEV RNA detection
Two out of four contact pigs seroconverted during the
observation period (wb87 at 25 dpi and mp63 at 28 dpi),
while the other two contact animals (mp68 and mp79)
developed no detectable HEV antibodies during this
time. Serological results are shown in Figure 2A. Only
wb87 was tested positive for viral RNA in serum with
over 10 copies per μL RNA at 28 dpi. Viral RNA in
faecal samples was detectable in all contact pigs with
over 10 copies per μL RNA after 7 dpi in wb87, and after
10 to 17 dpi in the miniature pigs. The results of HEV
RNA in serum and faeces are shown in Figure 2B. Viral
RNA was detected in liver, gall bladder, small and large
Figure 2 Serology and HEV RNA detection. Group 1: Intravenous inoculation of wild boar. Group 2: Intravenous inoculation of miniature pigs.
Group 3: Contact infection of wild boar and miniature pigs. A) Antibody responses to HEV in serum of inoculated wild boar and miniature pigs
measured by a double-antigen sandwich ELISA. OD450-values ≥1 are prescribed as seropositive – this threshold is indicated as a grey-dashed
line. B) HEV RNA in serum and faeces of HEV inoculated wild boar and miniature pigs estimated by RT-qPCR. * Sudden death at 1 dpi (after
blood collection).
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miniature pigs were tested positive for HEV RNA as
well, except for mp68. Compared to the contact mini-
ature pigs, higher viral copy numbers were detectable in
wb87. Table 3 summarises the viral loads of selected tis-
sue samples. Viral RNA was also found in bile of mp163
and wb87.
Pathology
No gross pathological changes specific for viral hepatitis
were seen in the livers of any of the contact animals, but a
mild follicular hyperplasia of lymphoid tissues in intestine
and of liver lymph nodes were frequently seen. Addition-
ally, moderate splenomegaly was found in the infected
contact wild boar. All contact animals showed a randomly
distributed multifocal mild lymphohistiocytic infiltration
in the liver associated with single cell necrosis (Figure 5A).
However, viral antigens were only found in the liver of thecontact wild boar (Figure 5B). In the miniature pigs, viral
antigens were demonstrated exclusively in the follicles of
the mandibular lymph nodes. An overview of gross le-
sions, histopathology and immunohistochemistry is given
in Table 1. All IHC results of viral antigen detection are
summarised in the Additional file 1.
Discussion
To date, the food-borne zoonotic transmission of HEV
gt3 in Europe is primarily associated with domestic pigs
[4], while data on the pathogenicity of HEV in wild boar
and their role in HEV transmission to domestic pigs are
missing. HEV prevalence studies in hunted wild boar
and serological studies in humans being in contact with
them suggest zoonotic transmissions [21,22,27,29-31].
Several HEV transmission studies in domestic pigs were
performed [35,36,38,40], but none involving wild boar.
Therefore, the current study was carried out to elucidate
Table 3 Results of RT-qPCR analysis of selected tissue samples from wild boar (wb) and miniature pigs (mp)
Tissue CT-value Goup 1. Intravenous inoculation
of wb
Group 2. Intravenous inoculation
of mp
Group 3. Contact infection of wb and mp
copies/μL RNA wb93 wb95 wb10 wb11 mp30* mp37 mp39 mp40 wb87 mp63 mp68 mp79
Liver 20.7 22.6 24.1 24.6 28.1 32.3 24.3 No CT 23.0 24.2 No CT 35.3
6521.0 2259.6 952.4 685.8 94.6 8.4 834.2 1763.9 888.8 1.5
Gall bladder 24.0 22.0 32.0 31.0 32.5 No CT 27.0 No CT 30.0 No CT No CT 35.9
991.5 3137.8 9.9 17.6 7.3 175.1 31.3 1.0
Duodenum 27.6 27.2 31.4 No CT 34.5 No CT 29.1 No CT 31.1 No CT No CT No CT
124.0 157.0 13.8 2.3 51.3 16.9
Jejunum 31.6 24.9 No CT No CT 34.1 No CT 31.8 No CT 29.6 No CT No CT No CT
12.3 577.0 3.0 11.0 40.3
Ileum 33.3 30.0 34.4 No CT 35.4 No CT 33.8 No CT 29.9 No CT No CT No CT
4.8 31.7 2.6 1.4 3.5 33.1
Caecum 25.9 32.3 35.3 34.8 35.5 No CT 26.5 No CT 25.0 35.9 No CT 35.0
337.7 8.4 1.5 2.0 1.3 23.,9 557.4 1.0 1.8
Colon 34.4 23.7 31.8 34.4 No CT No CT 28.9 33.8 25.0 34.2 No CT No CT
2.6 1171.8 10.8 2.4 60.7 3.6 557.4 2.7
Rectum 24.9 30.2 No CT No CT N. d. No CT 32.6 No CT 33.0 No CT No CT No CT
607.7 28.2 7.2 5.5
Pancreas No CT 34.7 No CT No CT N. d. No CT No CT No CT No CT No CT No CT No CT
2.1
Mandibular LN No CT No CT No CT 33.6 No CT No CT No CT No CT No CT No CT No CT No CT
3.9
Kidney 34.7 33.2 No CT No CT No CT No CT 31.7 No CT No CT No CT No CT No CT
2.0 5.0 11.6
Spleen 31.0 31.7 34.1 34.0 35.8 No CT 32.5 No CT 34.0 No CT No CT No CT
17.6 11.7 3.0 3.1 1.1 7.4 3.1
Heart No CT 33.9 32.6 No CT N. d. No CT No CT No CT 34.6 No CT No CT No CT
3.3 6.9 2.2
Brain 32.3 28.9 No CT No CT N. d. No CT No CT No CT No CT No CT No CT No CT
8.2 59.3
Muscle No CT 30.7 No CT No CT No CT No CT No CT No CT No CT No CT No CT No CT
20.7
Ovary/Testicle No CT 30.9 No CT No CT N. d. No CT No CT No CT No CT No CT No CT No CT
19.1
Uterus/Prostate No CT 30.6 No CT No CT N. d. No CT 35.0 No CT No CT No CT No CT No CT
22.3 1.8
Tissues were taken on days 29 (Group 2) and 28 (Group 1, Group 3). No CT ≥36.0 (= negative). Viral copy numbers in tissues were calculated from CT values
determined by RT-qPCR. LN = lymph node. N. d. = not determined. *Sudden death at 1 dpi (after blood collection).
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http://www.veterinaryresearch.org/content/45/1/121the transmission and pathogenesis of wild boar-derived
HEV gt3 in European wild boar and in miniature pigs.
Compared to common domesticated swine breeds, the
miniature pig offers several breeding and handling ad-
vantages. Miniature pigs have been used extensively
already in several fields of biomedical research [44], but
HEV infection studies have never been carried out in
this pig breed.The experimental inoculation of wild boar and mini-
ature pigs reveals an efficient HEV replication with sub-
stantial virus shedding. Following intravenous challenge
of wild boar, HEV infection was successfully transmitted
to contact animals. These contact animal infections
resemble the natural course of the disease. Wild boar-
derived HEV gt3 was detected in serum, faeces and differ-
ent tissues of all intravenously inoculated pigs. Moreover,
Figure 3 Histopathological alterations and immunohistochemistry of the liver from intravenously infected wild boar (Group 1) and
miniature pigs (Group 2). A) Hepatic lobules with moderate hyperaemia of sinusoids and portal fields (wb95). B) The lobules show swelling and
vacuolation of hepatocytes (wb95). C) Diffuse distribution of viral antigens within the liver lobules (wb95). D) Marked immunolabelling within a
hepatic lobule, intracytoplasmatic mainly in Kupffer cells (arrows) and liver sinusoidal endothelial cells (wb93). E) Multifocal hepatocellular
degeneration with focus on centrilobular areas (arrows) and hyperaemic central veins (wb11). F) Centrilobular area of hepatocellular degeneration
(apoptotic bodies) with infiltrates of lymphocytes, plasma cells and Kupffer cells (wb10). G) Viral antigens within the centrilobular area of a liver
lobule in association with degenerated hepatocytes and inflammatory infiltrates (wb11). H) Viral antigens within an area of hepatocellular
degeneration, mainly in association with Kupffer cells (arrows) and some hepatocytes (wb10). I) Hepatic lobule with mild hyperaemia of sinusoids
and portal fields (mp39). J) Areas of spotty necrosis and apoptotic bodies (arrows) with slight infiltrates of lymphocytes and Kupffer cells (mp37).
K) Diffuse distribution of viral antigens within the liver lobules (mp39). L) Intense immunolabelling within a hepatic lobule, mainly in association
with Kupffer cells and liver sinusoidal endothelial cells (mp39). All scale bars represent 100 μm.
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http://www.veterinaryresearch.org/content/45/1/121an early virus replication in the liver was observed in one
intravenously infected animal already at 1 dpi. Our find-
ings confirm that the liver is the primary location of HEV
replication. Extra-hepatic replication sites have been re-
ported [45] and in this study, HEV RNA or viral antigens
were also observed in liver, spleen and different lymph
nodes. Interestingly, HEV RNA was detected in the brain
of two out of four intravenously inoculated wild boar.
Neurotropic HEV gt3 variants in humans are under dis-
cussion and HEV RNA was detected recently in the cere-
brospinal fluid of patients with chronic HEV infection and
neurological symptoms [46]. Of course a contamination of
tissue specimens with HEV containing blood cannot beexcluded completely, but is rather unlikely as the viral
loads of all collected serum samples were mostly below
those detected in different tissue samples. The duration of
faecal HEV shedding in most intravenously inoculated pigs
was similar, but higher viral loads were found in faeces of
wild boar. In intravenously inoculated animals anti-HEV
antibodies were first time detected 14 dpi which is in line
with results obtained in previous studies [37,47]. However,
seroconversion between three and eight weeks post infec-
tion were more often reported [40,48]. The ELISA system
used in this study detects all classes of antibodies to HEV
in serum. Therefore, the rise of antibody titres observed in
the current experiment cannot be associated with a single
Figure 4 Immunohistochemistry of liver lymph node and spleen from intravenously HEV inoculated wild boar (Group 1). A) Viral
antigens in the subcapsular layer and in the germinal centre of secondary follicles of a liver lymph node (wb93). B) Splenic immunolabelling of
viral antigens in the germinal centre of a lymphoid follicle (wb11). All scale bars represent 100 μm.
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http://www.veterinaryresearch.org/content/45/1/121Ig class. HEV total antibody levels might be also influ-
enced by HEV-specific immunoglobulin (Ig) A in serum,
as IgA can be detected in serum of patients with hepatitis
E [49,50]. Moreover, a reduction of virus shedding in fae-
ces was observed in the intravenously inoculated pigs
which seroconverted after 14 to 17 dpi. Our findings sup-
port the hypothesis that adaptive immune responses are
crucial to control HEV infection [51].
The faecal-oral transmission of HEV is considered to
be the main transmission route among pigs [48]. Based
on a study in non-human primates, the infectious dose
of HEV required for oral infection is assumed to be
higher than for intravenous infection [52]. In our study,
the infectious dose of the contact animals remains un-
known. It can be assumed that the contact wild boar
might have had a higher exposure to HEV because of
their direct and permanent contact to excreta of the in-
fected animals than the miniature pigs which were only
exposed to collected faeces. As HEV RNA was detected
in urine of experimentally infected domestic pigs [35],Figure 5 Histopathological alterations and immunohistochemistry of
with inflammatory infiltrates mostly lymphocytes and histiocytes. B) Multifo
(arrows). All scale bars represent 100 μm.HEV might be also transmitted via urine. The reason for
the lacking antibody response in two contact miniature
pigs, despite elevated enzyme levels and viral shedding
via faeces, remains unclear. Most probably the duration
of the experiment was not long enough or the HEV in-
fection was not systemic, as described before [39]. In a
previous study it could be demonstrated that domestic
pigs could be infected orally, nevertheless, not each con-
tact pig was infected and the antibody response was less
efficient as compared to the intravenous inoculation
route [45].
In former studies only subclinical HEV infections have
been described in domestic pigs [35-37]. In the present
study a clinical course of HEV infection in pigs could be
proven, based on elevated γGT-levels in serum. In-
creased γGT-levels have also been reported for experi-
mentally HEV-infected non-human primates [53], but
not described for pigs before. Moreover, increased ALT
and BA serum levels were also observed, especially in
wild boar and to a lesser extent in miniature pigs. In thethe liver from the contact wild boar (Group 3). A) Intralobular area
cal distribution of viral antigens especially in centrilobular areas
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http://www.veterinaryresearch.org/content/45/1/121infected wild boar piglets the moderate clinical signs were
concomitant with increasing serum levels of BA and liver
enzymes. Obviously these results support laboratory find-
ings in humans with HEV infection which are similar to
other forms of viral hepatitis and characterised also by ele-
vated serum levels of ALT and γGT [54] due to marked
hepatic necrosis and cellular exhaustion of enzymes [55].
Also elevated levels of BA in serum are found in viral
hepatitis in humans [56]. The inter-individual variations in
these parameters may have resulted from factors such as
age, sex, physical condition and unrelated co-infections.
Swelling of hepatocytes with vacuolation of the cytoplasm
was seen in acute liver injury of domestic pigs as a result of
the HEV infection as described before [35]. Non-lipid hepa-
tocellular vacuolation is attributed to alterations in the in-
jured cell as a result of hydropic change, but may also
reflect a beneficial cellular adaptation rather than degenera-
tive change [51]. Especially in wild boar mild to moderate
intralobular lymphoplasmacytic or lymphohistiocytic infil-
trates with variable degree of hepatocellular degeneration
were found histopathologically. In previous studies micro-
scopic liver lesions with multifocal lymphoplasmacytic viral
hepatitis were observed in both experimentally [35,37] and
naturally [42] HEV infected domestic pigs. Our histopatho-
logical findings for hepatic lesions in the miniature pigs
were comparable, but varied for wild boar ranging from dif-
fuse moderate lesions with swelling, vacuolation and single
cell necrosis of hepatocytes and multifocal moderate to se-
vere hepatocellular degenerations.
Only few immunohistochemical studies on HEV in-
fected animals and humans have been published before
[57-60]. HEV has been shown to replicate in hepatocytes
and in extra-hepatic tissues such as small intestine, colon,
spleen, bile duct and lymph nodes [45,61]. By immunohis-
tochemistry, we were able to detect viral antigens mainly
in Kupffer cells and liver sinusoidal endothelial cells, par-
tially associated with hepatic lesions and infiltrates of
CD3-positive cells. Since Kupffer cells and liver sinusoidal
endothelial cells have antigen presenting functions [62],
they may also play a role in the host defense mechanisms
and immunopathogenesis. Anyhow, a virus proliferation
in these cells is possible, if not essential. Lymphatic tissue
might also represent extra-hepatic HEV replication sites,
as viral antigens were found in spleen, hepatic and man-
dibular lymph nodes. Interestingly, no viral antigens were
detected by immunohistochemistry in intestine as de-
scribed in a previous HEV infection study in gerbils [63].
Host cell injury in a viral infection may be mediated by
either a direct effect of the infectious agent or indirectly
through the antiviral host response, or a combination of
both. In this study, different patterns in the immunohisto-
chemical detection of HEV antigens and varying lesions
were seen in the liver. HEV antigens were either diffusely
distributed without association to liver lesions or associatedwith hepatocellular degeneration, especially in centri-
lobular areas. As HEV itself appears to be non-cytopathic
[64], an immunopathogenesis is assumed for hepatitis E
in humans [65]. Previous immunohistochemical studies
in liver biopsies of patients with acute hepatitis E re-
vealed that lymphocyte infiltrates consisted mainly of
CD3-positive T cells containing a predominantly cytotoxic
CD8-positive cell subpopulation which probably is playing
an important role in HEV-induced liver injury [66]. Inter-
estingly, CD3-positive T cell infiltrations within liver le-
sions were also observed in this study. The consistent
coincidence of infiltrates of lymphocytes, plasma cells and
histiocytes with hepatocellular degenerations and viral an-
tigens supports the assumption that liver damage in pigs
might also be immune-mediated.
Two different patterns within the course of HEV infec-
tion were observed: Animals with early anti-HEV serocon-
version are able to clear the virus, while animals with
lacking antibody responses suffered from prolonged HEV
persistence until the end of the investigation period. Per-
haps a weak cytotoxic response in pigs leads to viral persist-
ence, yet without obvious liver damage, whereas a sufficient
immune response may lead to an effective HEV clearance
that is accompanied by a variable degree of hepatic damage,
however. In humans the course of HEV infection can vary
substantially between different individuals and chronic
hepatitis E cases have been described in immunosuppressed
patients [65]. Recent studies in humans were able to associ-
ate the activation of the interferon system and viral evolu-
tion with severity or chronicity of hepatitis E [37]. Studies
in humans also revealed that chronic hepatitis E might be
associated with impaired HEV-specific T-cell responses and
enhancing adaptive cellular immunity against HEV might
prevent persistent HEV infections [36]. In swine factors like
virus titer, ratio of infectious to defective particles, route of
infection and host factors like the immune status, age of
exposure and the presence of co-infections have been dis-
cussed to modulate the clinical outcome of HEV infection
[27,28]. In the study presented here, some of the experi-
mental animals were carrying also nematodes and showed
mild gastrointestinal symptoms possibly caused by other in-
fectious agents affecting swine, but also by stress or a modi-
fied feeding regime. Wild boar piglets used in this study
were obtained from a local farmer, therefore pre-existing in-
fections with other pathogens cannot be excluded. Liver
homogenates given to the experimental animals were sterile
filtered to prevent parasitic and bacterial superinfections.
Moreover, clinical and pathological examinations showed
no indication of other infections. However, future studies
should clarify the impact of co-infections on the HEV
pathogenesis. Moreover, the pathomechanisms for the de-
velopment of persistent HEV infections in pigs should be
further assessed as this may provide an animal model for
the chronic hepatitis E infection in humans.
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http://www.veterinaryresearch.org/content/45/1/121Taken together, our data underline the importance of
wild boar as reservoir host and for transmission of HEV
gt3 to domestic swine and reveal Kupffer cells, liver si-
nusoidal endothelial cells and extra-hepatic lymphatic
cells as potential virus replication sites. Since large
amounts of virus particles are excreted in faeces of wild
boar, droppings can contaminate the environment and
pose a particular risk to susceptible species. Actually, in
most industrialised countries the HEV infected popula-
tion of domestic swine is far larger than those of the
wild boar. Accordingly, wild boar and other wildlife also
can be at infection risk by using pig manure as fertilizer
on agricultural land.
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